Drug Type AAV based gene therapy |
Synonyms AXO-AAV-FTD, AXO-AAV-TBD |
Target- |
Mechanism RNA interference |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | - | - | |
Dementia | Preclinical | - | - |